ARCHIVES

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

This article is from The Cancer Letter archive.

Vol. 12 No. 36 | September 19, 1986

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 27, 2002

House, Senate Meet On Appropriations Bill Differences

October 6, 1989

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

NCI, MABCO Publish Clinical Trials Web Site

September 6, 1996

In Brief: Four More O.I. Awards Announced; Pediatric Clinical Trials RFP Canceled

September 6, 1985